Analyst Barry Oxford of Colliers Securities maintained a Buy rating on American Healthcare REIT, Inc. (AHR – Research Report), boosting the price target to $40.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Barry Oxford has given his Buy rating due to a combination of factors including American Healthcare REIT’s impressive financial performance and strategic acquisitions. The company reported a strong same-store net operating income (NOI) growth of 15.1% year-over-year, driven by significant gains in their “SHOP” properties and integrated senior health campuses. This robust performance is further supported by the company’s ability to exceed earnings expectations, with normalized funds from operations (FFO) coming in higher than consensus estimates.
Additionally, the company has raised its guidance for 2025, reflecting confidence in continued strong operating results. The acquisition of the remaining minority stake in Trilogy and strategic property dispositions and acquisitions, including a significant SHOP property, demonstrate the company’s proactive management and growth strategy. With over $300 million available for future acquisitions, American Healthcare REIT is well-positioned for further expansion, supporting Barry Oxford’s optimistic outlook and Buy rating.
In another report released today, Citizens JMP also maintained a Buy rating on the stock with a $40.00 price target.